UNSPSC 51162009: Aminophylline/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162009 Aminophylline/phenobarbital is a Commodity code that appears in state and local solicitations focused on pharmaceutical procurement and pharmacy services, though recent opportunities show limited direct alignment with the code's nominal drug formulation. State and local government procurement under this code spans naloxone and drug deactivation systems for public health initiatives, on-site pharmacy services for government employee health plans, and participation in multi-state cooperative purchasing agreements for generic pharmaceuticals and over-the-counter products. Issuing bodies include county health departments and community health divisions (Seminole County, Florida), county government employee health programs (Hall County, Georgia), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances serving state and local facilities (Minnesota Multistate Cooperative Purchasing Alliance administering MMCAP with member participation from Oregon and other jurisdictions). These procurements emphasize vendor qualifications in pharmaceutical supply chain management, formulary compliance, insurance and compliance documentation, and cost competitiveness within structured evaluation frameworks that separate technical qualifications from pricing.

Recent activity spans Florida, Georgia, Texas, and Minnesota-based cooperative purchasing with multi-state reach. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2023 response date (note: posted date shows 2026 but response deadline appears to reflect 2023 data, suggesting documentation inconsistency). Hall County, Georgia issued RFQ/P #47-010 in May 2026 to procure on-site pharmacy services at its Family Health Center Clinic for approximately 3,005 enrolled employees and dependents, with an 80/20 technical-to-cost evaluation split and a June 4, 2026 response deadline. The Texas HHS Commission released RFI HHS0017013 in April 2026 to explore vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization arrangements. MMCAP, administered by Minnesota's Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be distributed to participating state and local facilities, with proposals due March 26, 2026, requiring vendor compliance with Good Manufacturing Practices, Drug Supply Chain Security Act certification, and authorized wholesaler relationships.